AACR Group Meetings

The AACR 2024 Annual Meeting has now passed

Thank you to everyone who chose participate in this year’s series of group meetings. We hope you found the updates and takeaways provided by the KOLs to be helpful.

Be sure to check back as we get closer to next year’s event to learn more about the upcoming sessions we will be hosting.

Will You Be Attending AACR 2025?

Saturday, April 26th and Sunday, April 27th, Guidepoint Insights will be hosting a series of group meetings featuring KOLs who will dive deeper into AACR 2025 updates. To be notified when more information becomes available regarding the specific topics and KOLs to be featured, please fill out the form below:

    How Will You Attend This Year's Event?

    Join Us At AACR 2025

    Saturday, April 26th and Sunday, April 27th, Guidepoint Insights will be hosting a series of group meetings featuring KOLs who will dive deeper into AACR 2025 updates.

      Sunday, April 7th
      9:00 AM PT (12:00 PM ET) - Jason Luke
      • Immunotherapy | Associate Professor, University of Pittsburgh School of Medicine
      10:00 AM PT (1:00 PM ET) - Igor Puzanov
      • Melanoma | Judith and Stanford Lipsey Chair in Clinical Cancer Research, Roswell Park Cancer Institute
      11:00 AM PT (2:00 PM ET) - Timothy Yap
      • Novel DDR Therapies | Medical Director, The University of Texas MD Anderson Cancer Center
      12:00 PM PT (3:00 PM ET) - Roger Greenberg
      • DDR Therapies | Professor at Perelman School of Medicine, University of Pennsylvania
      1:00 PM PT (4:00 PM ET) - Benjamin Neel
      • MAPK Pathway and PROTACs | Professor of Medicine, NYU Langone Health System
      2:00 PM PT (5:00 PM ET) - Thomas Marron
      • Immunotherapy/Lung | Associate Professor of Immunology, and Immunotherapy, Icahn School of Medicine at Mount Sinai
      Monday, April 8th
      11:00 AM PT (2:00 PM ET) - Rodabe Amaria
      • Melanoma | Associate Professor, Department of Melanoma Oncology, The University of Texas MD Anderson Cancer Center
      12:00 PM PT (3:00 PM ET) - Barbara Burtness
      • HNSCC | Chief Translational Research Officer, Yale University School Of Medicine
      2:00 PM PT (5:00 PM ET) - Ryan Corcoran
      • KRAS, RAF, and Colorectal Cancer | Director of the Gastrointestinal Cancer Center Program, and the Scientific Director of the Termeer Center for Targeted Therapies, Massachusetts General Hospital
      3:00 PM PT (6:00 PM ET) - David Hong
      • Early Phase Clinical | Associate VP of Clinical Research, The University of Texas MD Anderson Cancer Center

      *AACR Group Meetings will be 50 minutes long and available only to attendees. Group meetings are not recorded and transcripts will not be available following the event.